Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myelodysplastic syndromes

S M Utley1

  • 1Vanderbilt University Medical Center, Nashville, TN 37232-2415, USA.

Seminars in Oncology Nursing
|February 1, 1996
PubMed
Summary

Myelodysplastic syndromes (MDS) are blood disorders with ineffective blood cell production. Nursing care focuses on supportive measures, patient education, and managing fatigue to improve quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies.

Investigational new drugsยท1997
See all related articles

Area of Science:

  • Hematology
  • Oncology Nursing

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Characterized by ineffective hematopoiesis, peripheral blood cytopenias, and a high risk of transformation to acute myelogenous leukemia.

Purpose of the Study:

  • To establish a framework for nurses to collaborate with healthcare teams.
  • To guide the planning, coordination, and delivery of care for patients with MDS and their families.

Main Methods:

  • Comprehensive review of research studies, book chapters, and review articles.
  • Information gathered covers classification, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of MDS.

Main Results:

  • MDS involves ineffective blood cell production and cytopenias.
  • Potential for transformation into acute myelogenous leukemia is a key characteristic.

Conclusions:

  • Primary treatment for MDS is supportive care.
  • Chemotherapy, bone marrow transplant, and hematopoietic growth factors are also utilized.
  • Essential nursing interventions include assessment, education, emotional support, complication monitoring, and fatigue management.

Related Experiment Videos